```html

Yousef’s Ulcer (Corneal Ulcer) – A Comprehensive Medical Guide

Overview

A corneal ulcer, historically referred to in some Middle‑Eastern literature as “Yousef’s ulcer,” is an open‑sided defect in the cornea (the clear front surface of the eye) that is usually accompanied by inflammation and infection. It is a sight‑threatening condition that can progress rapidly if not treated promptly.

Who it affects

• All ages can develop a corneal ulcer, but the highest incidence is seen in adults 20–50 years old.
• Contact‑lens wearers, especially those who sleep with lenses, are at markedly higher risk.
• People in low‑ to middle‑income countries with limited access to clean water and eye‑care services account for roughly 70 % of global cases.<sup>WHO, 2022</sup>

Prevalence

• In the United States, the annual incidence of microbial keratitis (the umbrella term that includes corneal ulcers) is about 1–2 per 10,000 persons.<sup>CDC, 2023</sup>
• Globally, >2 million people develop a corneal ulcer each year, and up to 30 % of those cases can result in permanent visual impairment or blindness if untreated.<sup>Mayo Clinic</sup>

Symptoms

Symptoms can appear suddenly and may worsen over hours to days. The classic triad of a corneal ulcer includes:

• Eye pain – aching, burning, or a sharp stabbing sensation.
• Redness – intense injection of the conjunctiva (white part of the eye) around the ulcer.
• Reduced vision – blurred or hazy vision, sometimes described as “looking through a cloud.”

Additional signs and symptoms may include:

• Excessive tearing or watery discharge.
• Purulent (yellow/green) discharge, especially with bacterial infection.
• Photophobia – heightened sensitivity to light.
• Feeling of a foreign body or gritty sensation.
• Swelling of the eyelids (eyelid edema).
• White or greyish infiltrate (opacity) on the cornea visible on examination.
• In severe cases, a ring-shaped ulcer (“ring infiltrate”) often suggests fungal infection.

Causes and Risk Factors

Infectious Causes

• Bacterial: Pseudomonas aeruginosa (common in contact‑lens users), Staphylococcus aureus, Streptococcus pneumoniae.
• Fungal: Fusarium, Asp­ergillus, and Candida species—more frequent in tropical climates and after ocular trauma with vegetative matter.
• Viral: Herpes simplex virus (HSV) is a leading cause of recurrent corneal ulceration.
• Acanthamoeba: Rare but serious, linked strongly to poor contact‑lens hygiene.

Non‑Infectious Triggers

• Severe dry eye syndrome or exposure keratopathy.
• Autoimmune disorders (e.g., rheumatoid arthritis, Sjögren’s syndrome) causing peripheral ulcerative keratitis.
• Physical trauma – scratches, metal fragments, or chemical burns.
• Neurotrophic keratopathy – loss of corneal sensation (e.g., after trigeminal nerve injury).

Key Risk Factors

• Improper contact‑lens wear: overnight use, swimming with lenses, or using expired solution.<sup>CDC, 2022</sup>
• Eye injuries, especially with organic material (wood, soil).
• Pre‑existing ocular surface disease (dry eye, blepharitis).
• Systemic immunosuppression (diabetes, HIV, corticosteroid therapy).
• Living in warm, humid environments where fungal spores thrive.

Diagnosis

Prompt diagnosis is essential to preserve vision. An eye‑care professional will typically follow these steps:

Clinical Examination

• Visual acuity test – determines the degree of vision loss.
• Slit‑lamp biomicroscopy – provides a magnified view of the ulcer’s size, depth, and infiltrate pattern.
• Fluorescein staining – a drop of dye highlights the ulcer’s borders; the ulcer appears as a bright green defect under cobalt‑blue light.
• Seidel test – assesses leakage of aqueous humor in perforated ulcers.

Microbiological Work‑up

If an infectious cause is suspected, corneal scrapings are taken for:

• Gram stain and bacterial culture.
• Fungal stain (KOH) and culture.
• Polymerase chain reaction (PCR) for viral DNA (HSV) or Acanthamoeba.

Obtaining a sample before starting antibiotics improves diagnostic yield.

Imaging (Optional)

• Anterior segment optical coherence tomography (AS‑OCT) – measures ulcer depth and detects early stromal thinning.
• Ultrasound biomicroscopy – useful when corneal opacity limits view.

Treatment Options

Treatment is tailored to the underlying cause, ulcer size, depth, and presence of complications.

Empiric Antimicrobial Therapy

Most clinicians start broad‑spectrum antibiotics while awaiting culture results:

• Topical fluoroquinolone (e.g., moxifloxacin 0.5 % eye drops) – covers most gram‑negative bacteria, including Pseudomonas.
• Topical fortified antibiotics for severe cases:
  • Fortified cefazolin 5 % (gram‑positive coverage).
  • Fortified tobramycin 1.3 % or gentamicin 1.4 % (gram‑negative coverage).
• Adjunctive cycloplegic (e.g., homatropine) to relieve pain from ciliary spasm.

Specific Pathogen‑Directed Therapy

• Bacterial: Continue appropriate topical antibiotics based on sensitivities; systemic antibiotics rarely needed unless there is orbital involvement.
• Fungal: Natamycin 5 % eye drops (first‑line for filamentous fungi) or voriconazole 1 % drops for resistant cases.<sup>Cleveland Clinic</sup>
• Viral (HSV): Oral acyclovir 400 mg five times daily or valacyclovir 500 mg three times daily, plus topical antiviral (trifluridine) for active epithelial disease.
• Acanthamoeba: Combination therapy with polyhexamethylene biguanide (PHMB) 0.02 % and chlorhexidine 0.02 % drops, often for a prolonged course (months).

Surgical Interventions

When medical therapy fails or the ulcer threatens perforation, surgical options include:

• Debridement: Removal of necrotic tissue to improve drug penetration.
• Therapeutic penetrating keratoplasty (PK) or lamellar keratoplasty: Corneal transplant to restore structural integrity.
• Amniotic membrane transplantation: Promotes healing and reduces scarring in non‑perforating ulcers.
• Corneal collagen cross‑linking (CXL): Emerging adjunct to stabilize thin corneas and inhibit microbial growth.

Lifestyle and Supportive Measures

• Frequent lubrication with preservative‑free artificial tears.
• Protect the eye with a shield (especially at night) to prevent inadvertent rubbing.
• Avoid contact lenses until the ulcer fully resolves and the cornea is fully re‑epithelialized.
• Strict hand hygiene before any eye‑drop administration.

Living with Yousef’s Ulcer (Corneal Ulcer)

Even after the acute phase, patients may need ongoing care to preserve vision.

Daily Management Tips

• Adherence to medication schedule: Missing doses can allow organisms to proliferate and increase resistance.
• Monitor symptoms: Keep a diary of pain level, discharge, and visual changes; report any worsening immediately.
• Protective eyewear: Use sunglasses with UV protection to reduce photophobia and prevent further UV‑induced damage.
• Follow‑up appointments: Typically every 24–48 hours initially, then weekly until the ulcer is stable.
• Nutrition: Adequate omega‑3 fatty acids (found in fish, flaxseed) may support ocular surface health.

Psychological Considerations

Vision loss can cause anxiety and depression. Patients are encouraged to seek counseling, join support groups, or use mental‑health resources offered by ophthalmology clinics.

Prevention

• Contact‑lens hygiene: Wash hands, use fresh solution daily, never sleep or swim with lenses, replace lenses as scheduled.
• Eye protection: Wear safety goggles during activities with dust, metal, or chemicals.
• Prompt treatment of minor injuries: Rinse the eye with sterile saline and seek care if pain, redness, or vision change occurs.
• Manage dry eye: Use lubricating drops and address underlying conditions (e.g., meibomian gland dysfunction).
• Regular eye examinations: At least once a year for healthy adults; more often for contact‑lens wearers or those with systemic disease.

Complications

If a corneal ulcer is not adequately treated, several serious sequelae may arise:

• Corneal scarring: Permanent opacity leading to reduced visual acuity.
• Corneal perforation: Full‑thickness loss, requiring emergency surgery and possibly resulting in loss of the eye.
• Endophthalmitis: Infection spreading to intra‑ocular structures—vision‑threatening emergency.
• Secondary glaucoma: Elevated intra‑ocular pressure from inflammation or steroid use.
• Symblepharon or ankyloblepharon: Adhesions between eyelid and globe causing restricted eye movement.
• Recurrence: Especially with viral etiology; prophylactic antiviral therapy may be needed.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, WHO, Cleveland Clinic, National Eye Institute (NEI), peer‑reviewed journals – Ophthalmology 2023; Cornea 2022; American Journal of Ophthalmology 2021.

```